Compare HRMY & HTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | HTZ |
|---|---|---|
| Founded | 2017 | 1918 |
| Country | United States | United States |
| Employees | N/A | 26000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Rental/Leasing Companies |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2020 | N/A |
| Metric | HRMY | HTZ |
|---|---|---|
| Price | $31.05 | $6.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $44.11 | $5.67 |
| AVG Volume (30 Days) | 793.3K | ★ 15.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.97 | N/A |
| EPS | ★ 2.71 | N/A |
| Revenue | ★ $868,453,000.00 | N/A |
| Revenue This Year | $19.75 | $4.94 |
| Revenue Next Year | $12.88 | $3.62 |
| P/E Ratio | $12.04 | ★ N/A |
| Revenue Growth | ★ 21.51 | N/A |
| 52 Week Low | $25.52 | $3.78 |
| 52 Week High | $40.87 | $8.44 |
| Indicator | HRMY | HTZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 51.91 |
| Support Level | $25.92 | $4.98 |
| Resistance Level | $30.96 | $7.24 |
| Average True Range (ATR) | 1.47 | 0.63 |
| MACD | 0.07 | -0.08 |
| Stochastic Oscillator | 35.36 | 26.51 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.